CCapital Cell
Capital Cell is a Barcelona-based equity crowdfunding platform that invests only in biotechnology and life sciences. Founded in 2015 and authorised by Spain's CNMV, it lets retail investors, business angels and venture capital firms co-invest in early-stage companies working on therapeutics, diagnostics, digital health, genomics, drug discovery, drug delivery and regenerative medicine. Its BioExpert Network of more than 3,500 specialists vets applicants, and about 3% of them are accepted. The platform has completed about 170 funding rounds with €162M invested in total, typically raising €0.16–3M per round. Its portfolio includes fetaLife, VRAIn Medical, Aspivix, Cardiawave and Womed. Its exits include the IPO of Vytrus and the sale of GoodGut to HIPRA, and Bionure went on to become Accure Therapeutics.
Profile updated 23 Sep 2026
Team
Portfolio companies 44
2
A
A
A
A
A
A
A
B
B
C
C
C
C
D
D
E
E
F
F
G
H
I
K
L
L
M
M
M
M
M
O
O
O
P
R
R
T
V
ZFunding rounds 29
News & media 7
| Published | Article |
|---|---|
| 2026-07-14 |
Capital Cell: la plataforma líder en Europa en equity crowdfunding para biotecnología y ciencias de la salud ↗
Universo Crowdfunding
|
| 2025-07-28 |
Daniel Oliver (Capital Cell): "La inversión debe ayudar a la máquina que es Catalunya a nivel científico" ↗
The New Barcelona Post
|
| 2024-07-15 |
Hemerion launches a crowdfunding campaign to finance its glioblastoma therapy ↗
Hemerion (press release)
|
| 2024-07-12 |
Successful Crowdfunding Campaign with Capital Cell ↗
Flomics (press release)
|
| 2024-03-04 |
Perha Pharmaceuticals retenue par Capital Cell, la seule plateforme européenne de crowdfunding spécialisée en santé et en biotechnologie ↗
Technopôle Brest-Iroise
|
| 2024-01-24 |
Capital Cell closes a €650K round to strengthen its internationalization ↗
Catalonia.health
|
| 2023-12-20 |
SeedBlink and Capital Cell partner to boost European tech startups' financing in Biotech and Healthtech ↗
SeedBlink Press Room
|